NEA Management Company, LLC

Registered adviser

CIK

1512848

Location

TIMONIUM, MD

Portfolio Value

Mid $1,587,937,444

Diversification

Diversified

Filing Date

Global Rank

#1,883 / 8,818 ▼ 312

Top Industry

Biotechnology 94.8%

Period ended 4 months ago

Filed Aug 14, 2026 · 2mo

26 quarters · since Mar 2020

Regulatory profile

From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.

Holder type

Registered adviser

Form ADV roster, Oct 1, 2026

Form ADV adviser

CRD 161004

Roster of Oct 1, 2026

Regulatory AUM

$35,582,968,154

Main clients

Pooled investment vehicles (100% of AUM)

Private funds

27 funds · Venture capital funds

Focus by gross assets, Schedule D of Nov 25, 2024

$35,582,968,153 gross assets

Private funds on Schedule D 7.B.(1)

As filed Nov 25, 2024; SEC's bulk Form ADV archive ends with 2024 filings.

$26,539,439,661 gross assets in 19 funds Venture capital funds $25,912,724,687 (18) Private equity funds $626,714,974 (1)

Form ADV history

Monthly rosters from Dec 2019; each row is a run with the same figures, newest first.

Rosters	Regulatory AUM	Main clients
Apr 2026 to Oct 2026	$35,582,968,154	Pooled investment vehicles (100%)
Apr 2025 to Mar 2026	$27,827,259,258	Pooled investment vehicles (100%)
Dec 2024 to Mar 2025	$25,912,724,688	Pooled investment vehicles (100%)
Apr 2024 to Nov 2024	$25,912,724,688	Pooled investment vehicles (100%)
May 2023 to Mar 2024	$25,911,756,571	Pooled investment vehicles (100%)
Apr 2023	$25,911,756,571	Pooled investment vehicles (100%)

2 earlier changes not shown.

Portfolio style

Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.

Style

Concentrated

The top 10 positions are 89.8% of the book (60%+)

Turnover

Low turnover

14.6% over the last four quarters (under 30%)

Horizon

Long horizon

Value-weighted holding period 16.5 quarters (12+), a floor since 24.7% of the book was already held when coverage starts

Closest benchmark: the Russell 2000 as of 2026-06-30, active share 99.3%; sector active share 87.4% against the combined 13F book's sector weights.

Over time 26 measured quarters

How the bands are measured

Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

26 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026

Top Position

15.5%

−4.3 pts

Top 5

61.4%

−0.7 pts

Top 10

89.8%

+2.3 pts

HHI

968

Diversified−64

Portfolio Trend

26 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026

Sector	% Portfolio	Value	Positions
Healthcare	95.4%	$1,515,363,227	25
Consumer Defensive	4.6%	$72,574,217	1

Last Quarter's Activity

Export CSV

Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased

No qualifying positions this quarter.

Trimmed

Positions the filer reduced

2 positions

Ticker	Company	Δ Shares	Shares	Value
CELC	Celcuity Inc.	−575,000	1,710,561	$178,958,891
CVRX	CVRx, Inc.	−71,643	1,954,440	$10,045,821
No positions match the current search.

New Positions

Positions the filer opened this quarter

1 positions

Ticker	Company	Shares	Value	Open
KPTI	Karyopharm Therapeutics Inc.	576,780	$5,635,140
No positions match the current search.

Sold Out

Positions the filer fully exited

1 positions

Ticker	Company	Shares	Value	Open
—		3,045,262	$349,656,983
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

26 tracked positions · $1,587,937,444 total · filing declares 26 positions · $1,587,937,058 · as of Jun 30, 2026

All sectors Consumer Defensive Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	Held (qtrs)	Est. cost/share	% of Portfolio
TRVI	Trevi Therapeutics, Inc. Healthcare	Held	13,222,228	0	$246,594,552	+56.3%	26+	before history	15.53%
MBX	MBX Biosciences, Inc. Healthcare	Held	3,614,486	0	$199,519,627	+84.9%	8	unpriced	12.56%
GLUE	Monte Rosa Therapeutics, Inc. Healthcare	Held	7,692,298	0	$186,153,611	+47.1%	21	unpriced	11.72%
CELC	Celcuity Inc. Healthcare	Reduced	1,710,561	-575,000	$178,958,891	−31.4%	15	$38.74	11.27%
SGP	SpyGlass Pharma, Inc. Healthcare	Held	7,392,301	0	$164,552,620	−14.1%	2	$26.90	10.36%
SVRA	Savara Inc Healthcare	Held	24,471,264	0	$150,742,986	+12.8%	22	$1.74	9.49%
ZBIO	Zenas BioPharma, Inc. Healthcare	Held	4,023,219	0	$102,109,298	+29.8%	8	unpriced	6.43%
COUR	Coursera, Inc. Consumer Defensive	Held	12,867,769	0	$72,574,217	−3.1%	22	unpriced	4.57%
AUPH	Aurinia Pharmaceuticals Inc. Healthcare	Held	3,969,834	0	$67,368,082	+14.5%	26+	before history	4.24%
CRSP	CRISPR Therapeutics AG Healthcare	Held	1,058,570	0	$57,734,407	+14.7%	26+	before history	3.64%
ORIC	Oric Pharmaceuticals, Inc. Healthcare	Held	4,118,621	0	$44,604,665	−14.5%	10	$8.94	2.81%
PHAT	Phathom Pharmaceuticals, Inc. Healthcare	Held	1,960,169	0	$21,267,833	−2.3%	13	$10.51	1.34%
KRRO	Korro Bio, Inc. Healthcare	Held	1,297,893	0	$17,106,229	+16.4%	11	unpriced	1.08%
XFOR	X4 Pharmaceuticals, Inc Healthcare	Held	3,233,743	0	$15,101,579	+13.1%	16	$9.10	0.95%
CSBR	Champions Oncology, Inc. Healthcare	Held	1,713,720	0	$10,556,515	+7.1%	26+	before history	0.66%
NKTX	Nkarta, Inc. Healthcare	Held	3,568,781	0	$10,099,650	+34.1%	24	$26.42	0.64%
CVRX	CVRx, Inc. Healthcare	Reduced	1,954,440	-71,643	$10,045,821	−47.6%	21	unpriced	0.63%
BDTX	Black Diamond Therapeutics, Inc. Healthcare	Held	4,448,757	0	$8,230,200	−13.1%	26+	before history	0.52%
KPTI	Karyopharm Therapeutics Inc. Healthcare	NEW	576,780	NEW	$5,635,140	NEW	1	$8.67	0.35%
IVA	Inventiva S.A. Healthcare	Held	1,462,586	0	$5,528,575	−31.9%	24	$9.72	0.35%
LONA	LeonaBio, Inc. Healthcare	Held	464,398	0	$4,267,817	−10.6%	3	$4.58	0.27%
SNTI	Senti Biosciences Holdings, Inc. Healthcare	Held	3,775,615	0	$4,153,176	+35.5%	8	unpriced	0.26%
MRKR	Marker Therapeutics, Inc. Healthcare	Held	1,625,678	0	$2,389,746	+13.1%	26+	before history	0.15%
OKUR	OnKure Therapeutics, Inc. Healthcare	Held	478,548	0	$2,182,178	+10.1%	7	unpriced	0.14%
IMA	ImageneBio, Inc. Healthcare	Held	50,005	0	$295,029	+18.0%	4	unpriced	0.02%
GOSS	Gossamer Bio, Inc. Healthcare	Held	1,000,000	0	$165,000	−49.8%	16	$3.26	0.01%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.